Focus Investment Banking

MARCH 28, 2024

Summary Private equity’s investments in ophthalmology are entering a new, more mature lifecycle phase. We also expect many platform recapitalizations once private equity groups and lenders become comfortable with the interest rate environment. Most ophthalmology PPM organizations are still with their founding private equity sponsor.

Private Equity 52

Private Equity Equities Valuation Acquisitions 52

Peak Frameworks

SEPTEMBER 11, 2023

Incorporating Fringe Benefits into Compensation Negotiations Understanding the value of fringe benefits can significantly impact your negotiation strategy when starting a new job or seeking a raise. It's essential to understand the tax implications of your benefits package.

Insurance 52

Insurance Negotiation Investment Private Equity 52

Devensoft

AUGUST 22, 2023

Properly valuing a company involved in an M&A transaction allows stakeholders to make informed decisions and negotiate effectively. Enterprise Value Calculators are financial tools designed to help businesses and investors determine the total value of a company, including its equity and debt.

Valuation 52

Valuation M&A Utilities Mergers and Acquisitions 52

Software Equity Group

JANUARY 22, 2024

The focus on mental and behavioral health The world’s collective medical knowledge continues to grow and evolve, and today, the healthcare community is placing greater emphasis on the inextricable relationship between physical and mental well-being. Click here to fill out our assessment form.

Healthcare 52

Healthcare M&A Valuation Medical 52

Software Equity Group

JANUARY 22, 2024

The focus on mental and behavioral health The world’s collective medical knowledge continues to grow and evolve, and today, the healthcare community is placing greater emphasis on the inextricable relationship between physical and mental well-being. Click here to fill out our assessment form.

Healthcare 52

Healthcare M&A Valuation Medical 52

Cooley M&A

JANUARY 25, 2023

But it wasn’t all carve outs and concerned investors – even with the headwinds in the industry and beyond, there were still several traditional public M&A deals involving biotechnology or medical device companies, as large pharmaceutical companies continued to have cash to deploy for acquisitions.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

Cooley M&A

JANUARY 20, 2022

In November, Johnson & Johnson announced that it will split itself into two publicly traded companies , separating its pharmaceutical and medical devices businesses from its consumer products business. billion strategic combination of One Medical and Iora Health – used all stock. [9] 19 fueled revenue aside, cash is still king.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Mergers 40

Cooley M&A

JANUARY 25, 2024

Acquirers must be prepared for potential litigation domestically and internationally, and for more detailed negotiations over regulatory and interim operating covenants. In addition, acquirers’ appetite for mega-deals may continue to be more suppressed, and acquirers may pivot to smaller M&A opportunities.

M&A 52

M&A Mergers and Acquisitions Investment Government 52

Cooley M&A

JANUARY 25, 2023

However, deal activity fizzled in the second half of 2022, as high inflation, aggressive anti-inflation monetary policies, geopolitical instability, assertive antitrust regulators and tightening financing markets depressed target valuations, reduced strategic acquirer confidence and sidelined private equity sponsor buyers. trillion. [2]

M&A 52

M&A Mergers and Acquisitions Private Equity Mergers 52

Focus Investment Banking

MARCH 7, 2025

Private equity investments in healthcare provider practices are getting more mature and changing the way buyers and sellers approach transactions. Deal activity has been high across dentistry, veterinary, and the physician specialties, with more than 100 private equity backed platforms established and completing their own add-on deals.

Healthcare 52

Healthcare Private Equity Equities Professional Services 52

Lake Country Advisors

JANUARY 13, 2025

This data-driven approach provides a comprehensive valuation, ensuring realistic expectations and a stronger position during negotiations with buyers. Financial Buyers : Private equity firms and investment groups interested in businesses with strong cash flow and growth potential.

Broker 52

Broker M&A Business Negotiation 52

Lake Country Advisors

FEBRUARY 14, 2025

A specialized broker ensures that every stage of the sale is handled with precision, from valuation and compliance to buyer targeting and negotiation. Industry connections Access to pre-vetted investors, private equity firms, and business operators seeking expansion.

Broker 52

Broker Business Valuation Healthcare 52

Mergers and Inquisitions

MARCH 19, 2025

Consumer retail private equity is so diverse that it almost seems like a paradox. Depending on the firm, a consumer retail private equity deal might consist of: A leveraged buyout of a struggling offline retailer. On the Job Recruiting Should You Go Shopping for Consumer Retail Private Equity Jobs?

Private Equity 59

Private Equity Retail Equities Mergers and Acquisitions 59